Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 12,454.80 -74.92 -0.60%
S&P 500 1,317.82 -2.86 -0.22%
Nasdaq 2,837.53 -1.85 -0.07%
Ticker Volume Price Price Delta
STOXX 50 2,161.87 +5.35 0.25%
FTSE 100 5,351.53 +1.48 0.03%
DAX 6,339.94 +24.05 0.38%
Ticker Volume Price Price Delta
Nikkei 8,580.39 +17.01 0.20%
TOPIX 722.11 -0.14 -0.02%
Hang Seng 18,713.40 +47.01 0.25%
Gold 1,571.20 +0.73%
EUR-USD 1.2517 -0.1227%
Nasdaq 2,837.53 -0.07%
DJIA 12,454.80 -0.60%
S&P 500 1,317.82 -0.22%
FTSE 100 5,351.53 +0.03%
STOXX 50 2,161.87 +0.25%
DAX 6,339.94 +0.38%
Oil (WTI) 90.86 +0.22%
U.S. 10-year 1.738% -0.039
BAC:US 7.15 +0.14%
FB:US 31.91 -3.39%
  • Exchange: JASDAQ
  • Sector: Consumer, Non-cyclical
  • Industry: Biotechnology
  • Sub-Industry: Medical-Biomedical/Gene

Japan Tissue Engineering Co Ltd

Add to Portfolio

7774:JT

Price not available for 7774:JT

Snapshot for Japan Tissue Engineering Co Ltd (7774)

Open: - Day's Range: - Volume: 0 Bid: -
Previous Close: - 52wk Range: - 1-Yr Rtn: - Ask: -

Stock Chart for 7774

No chart data available.
  • 7774:JT
  • 1M
  • 1Y
0
Interactive 7774 Chart

Previous Close

Key Statistics for 7774

Current P/E Ratio (ttm) -
Estimated P/E (03/2013) -
Earnings Per Share () (ttm) -5,996.9400
Est. EPS (03/2013) -
Est. PEG Ratio -
Market Cap (M JPY) 0.00
Shares Outstanding (M) 0.18
Enterprise Value (M JPY) (ttm) -
Enterprise Value/EBITDA (ttm) -
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 0.0000
Next Earnings Announcement 07/27/2012
More 7774 Key Statistics mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Financials for 7774

  • Revenue
  • Net Income (M/JPY)
  • Profit Margin (%)
More 7774 Income Statement Data
  • Total Assets
  • Total Liabilities (M/JPY)
  • Debt to Assets (%)
More 7774 Balance Sheet Data
  • Operating
  • Investing
  • Financing (M/JPY)
More 7774 Cash Flow Data

Company Profile & Key Executives for 7774

Japan Tissue Engineering Company., Ltd. is a medical biotechnology company. The Company develops regenerative medicine using tissue engineering technology. Japan Tissue Engineering also provides research support services.

Yosuke OzawaPresident/CEOToshihiro OhsukaSenior Managing Director
Kenichiro HataManaging DirectorYukio MoriDirector
More Company Profile & Key Executives for 7774

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Advertisements